PureTech Health (0VQ) Ratios

0 Followers

PureTech Health Ratios

DE:0VQ's free cash flow for Q4 2025 was $0.41. For the 2025 fiscal year, DE:0VQ's free cash flow was decreased by $ and operating cash flow was $-18.02. See a summary of the company’s cash flow.

Ratios	TTM	Dec 25	Dec 24	Dec 23	Dec 22
Liquidity Ratios
Current Ratio	6.59	6.59	9.33	6.76	3.99
Quick Ratio	6.59	6.59	9.33	6.76	3.99
Cash Ratio	5.49	5.49	6.78	3.72	1.55
Solvency Ratio	-0.46	-0.47	0.29	-0.26	-0.27
Operating Cash Flow Ratio	-1.83	-1.88	-3.25	-2.06	-1.85
Short-Term Operating Cash Flow Coverage	-17.25	-17.68	-32.69	-28.63	-23.84
Net Current Asset Value	$ 75.98M	$ 76.01M	$ 191.55M	$ 111.46M	$ 231.13M
Leverage Ratios
Debt-to-Assets Ratio	0.04	0.04	0.26	0.04	0.07
Debt-to-Equity Ratio	0.06	0.06	0.38	0.05	0.09
Debt-to-Capital Ratio	0.06	0.06	0.28	0.05	0.08
Long-Term Debt-to-Capital Ratio	0.00	0.00	0.25	0.00	0.02
Financial Leverage Ratio	1.71	1.71	1.45	1.50	1.30
Debt Service Coverage Ratio	-1.86	-1.86	2.93	-2.80	-2.11
Interest Coverage Ratio	-2.16	-2.15	-13.56	-10.84	-50.04
Debt to Market Cap	0.01	0.01	0.28	<0.01	0.02
Interest Debt Per Share	27.02	0.28	0.63	0.14	0.18
Net Debt to EBITDA	2.47	2.41	-3.25	9.37	1.29
Profitability Margins
Gross Profit Margin	-471.15%	28.14%	100.00%	-12387.33%	-6546.17%
EBIT Margin	-2115.43%	-2114.72%	783.57%	-3015.33%	-4250.24%
EBITDA Margin	-2043.54%	-2042.86%	866.33%	-2357.47%	-3824.74%
Operating Profit Margin	-2115.41%	-2114.72%	-3154.00%	-19493.20%	-9464.45%
Pretax Profit Margin	-2380.86%	-2380.90%	550.96%	-4813.73%	-4439.38%
Net Profit Margin	-2355.50%	-2355.42%	1240.09%	-8759.60%	-2409.28%
Continuous Operations Profit Margin	-2362.91%	-2362.83%	643.85%	-8883.73%	-1773.44%
Net Income Per EBT	98.93%	98.93%	225.08%	181.97%	54.27%
EBT Per EBIT	112.55%	112.59%	-17.47%	24.69%	46.91%
Return on Assets (ROA)	-20.48%	-20.95%	8.88%	-9.47%	-7.17%
Return on Equity (ROE)	-31.83%	-35.89%	12.90%	-14.16%	-9.29%
Return on Capital Employed (ROCE)	-20.13%	-20.59%	-24.25%	-22.75%	-32.65%
Return on Invested Capital (ROIC)	-19.64%	-20.08%	-23.92%	-22.50%	-12.78%
Return on Tangible Assets	-20.50%	-20.97%	8.89%	-9.48%	-7.17%
Earnings Yield	-261.03%	-27.67%	10.56%	-9.71%	-5.59%
Efficiency Ratios
Receivables Turnover	0.57	0.58	0.33	0.32	0.17
Payables Turnover	8.65	1.11	0.51	6.40	5.75
Inventory Turnover	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.40	0.41	0.29	0.04	0.06
Asset Turnover	<0.01	<0.01	<0.01	<0.01	<0.01
Working Capital Turnover Ratio	0.02	0.02	0.01	<0.01	<0.01
Cash Conversion Cycle	596.17	296.13	370.23	1.10K	2.09K
Days of Sales Outstanding	638.37	624.07	1.09K	1.16K	2.15K
Days of Inventory Outstanding	0.00	0.00	0.00	0.00	0.00
Days of Payables Outstanding	42.21	327.93	721.22	57.04	63.46
Operating Cycle	638.37	624.07	1.09K	1.16K	2.15K
Cash Flow Ratios
Operating Cash Flow Per Share	-35.14	-0.36	-0.50	-0.39	-0.64
Free Cash Flow Per Share	-35.14	-0.36	-0.50	-0.39	-0.65
CapEx Per Share	<0.01	<0.01	<0.01	<0.01	<0.01
Free Cash Flow to Operating Cash Flow	1.00	1.00	1.00	1.00	1.01
Dividend Paid and CapEx Coverage Ratio	-14.18K	-14.18K	-12.22K	-432.31	-82.17
Capital Expenditure Coverage Ratio	-14.18K	-14.18K	-12.22K	-432.31	-82.17
Operating Cash Flow Coverage Ratio	-4.33	-4.40	-0.84	-4.18	-3.81
Operating Cash Flow to Sales Ratio	-18.25	-18.27	-31.14	-141.22	-85.55
Free Cash Flow Yield	-20.05%	-21.46%	-26.52%	-15.69%	-20.08%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	-0.60	-3.58	9.40	-10.30	-17.89
Price-to-Sales (P/S) Ratio	91.02	85.14	117.44	902.30	431.11
Price-to-Book (P/B) Ratio	0.13	1.30	1.22	1.46	1.66
Price-to-Free Cash Flow (P/FCF) Ratio	-4.99	-4.66	-3.77	-6.37	-4.98
Price-to-Operating Cash Flow Ratio	-0.49	-4.66	-3.77	-6.39	-5.04
Price-to-Earnings Growth (PEG) Ratio	<0.01	0.01	-0.05	-0.31	1.25
Price-to-Fair Value	0.13	1.30	1.22	1.46	1.66
Enterprise Value Multiple	-1.99	-1.76	10.31	-28.90	-9.98
Enterprise Value	188.61M	170.59M	385.24M	510.99M	798.02M
EV to EBITDA	-1.99	-1.76	10.31	-28.90	-9.98
EV to Sales	40.58	35.86	89.28	681.32	381.83
EV to Free Cash Flow	-2.22	-1.96	-2.87	-4.81	-4.41
EV to Operating Cash Flow	-2.22	-1.96	-2.87	-4.82	-4.46
Tangible Book Value Per Share	126.40	1.27	1.51	1.67	1.95
Shareholders’ Equity Per Share	129.30	1.30	1.54	1.70	1.94
Tax and Other Ratios
Effective Tax Rate	<0.01	<0.01	-0.17	-0.85	0.60
Revenue Per Share	1.93	0.02	0.02	<0.01	<0.01
Net Income Per Share	-45.37	-0.47	0.20	-0.24	-0.18
Tax Burden	0.99	0.99	2.25	1.82	0.54
Interest Burden	1.13	1.13	0.70	1.60	1.04
Research & Development to Revenue	12.14	12.14	12.58	128.31	55.56
SG&A to Revenue	9.66	4.34	6.37	33.57	17.07
Stock-Based Compensation to Revenue	1.02	1.73	5.30	5.89	7.03
Income Quality	0.77	0.79	-4.84	1.59	4.82

Currency in USD